Literature DB >> 1458760

The role of pharmacokinetics in the development of biotechnologically derived agents.

R J Wills1, B L Ferraiolo.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1458760     DOI： 10.2165/00003088-199223060-00002

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  50 in total

Review 1.  A decade of development in immunoassay methodology.

Authors:  J P Gosling
Journal:  Clin Chem       Date:  1990-08       Impact factor: 8.327

2.  Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus.

Authors:  L A Frohman; T R Downs; T C Williams; E P Heimer; Y C Pan; A M Felix
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

3.  Protein blotting and immunodetection.

Authors:  T M Timmons; B S Dunbar
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 4.  Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review.

Authors:  T Maack; V Johnson; S T Kau; J Figueiredo; D Sigulem
Journal:  Kidney Int       Date:  1979-09       Impact factor: 10.612

5.  Interferon kinetics and adverse reactions after intravenous, intramuscular, and subcutaneous injection.

Authors:  R J Wills; S Dennis; H E Spiegel; D M Gibson; P I Nadler
Journal:  Clin Pharmacol Ther       Date:  1984-05       Impact factor: 6.875

6.  Quantification of recombinant interleukin-2 in human serum by a specific immunobioassay.

Authors:  R W Nadeau; N F Oldfield; W A Garland; D J Liberato
Journal:  Anal Chem       Date:  1989-08-01       Impact factor: 6.986

7.  Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion.

Authors:  M L Vance; D L Kaiser; W S Evans; R Furlanetto; W Vale; J Rivier; M O Thorner
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

8.  Metabolic interaction of recombinant interferon-beta and zidovudine in AIDS patients.

Authors:  M Nokta; J P Loh; S M Douidar; A E Ahmed; R B Pollard
Journal:  J Interferon Res       Date:  1991-06

9.  Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients.

Authors:  R Kurzrock; M G Rosenblum; S A Sherwin; A Rios; M Talpaz; J R Quesada; J U Gutterman
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

10.  Effect of desialylation of human chorionic gonadotropin on its metabolic clearance rate in humans.

Authors:  C Rosa; S Amr; S Birken; R Wehmann; B Nisula
Journal:  J Clin Endocrinol Metab       Date:  1984-12       Impact factor: 5.958
View more
  5 in total

1.  Influence of aggregation on immunogenicity of recombinant human Factor VIII in hemophilia A mice.

Authors:  Vivek S Purohit; C Russell Middaugh; Sathyamangalam V Balasubramanian
Journal:  J Pharm Sci       Date:  2006-02       Impact factor: 3.534

2.  Specificity and accuracy data for ligand-binding assays for macromolecules should be interpreted with caution.

Authors:  John W A Findlay
Journal:  AAPS J       Date:  2008-07-17       Impact factor: 4.009

Review 3.  Pegylation: a novel process for modifying pharmacokinetics.

Authors:  J M Harris; N E Martin; M Modi
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 4.  Effects of route and formulation on clinical pharmacokinetics of interleukin-2.

Authors:  P M Anderson; M A Sorenson
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

5.  Highly aggregated antibody therapeutics can enhance the in vitro innate and late-stage T-cell immune responses.

Authors:  Marisa K Joubert; Martha Hokom; Catherine Eakin; Lei Zhou; Meghana Deshpande; Matthew P Baker; Theresa J Goletz; Bruce A Kerwin; Naren Chirmule; Linda O Narhi; Vibha Jawa
Journal:  J Biol Chem       Date:  2012-05-14       Impact factor: 5.157
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.